107 related articles for article (PubMed ID: 9672996)
1. The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A.
Macchioni P; Boiardi L; Cremonesi T; Battistel B; Casadei-Maldini M; Beltrandi E; Mancini R; Salvarani C
Rheumatol Int; 1998; 18(1):27-33. PubMed ID: 9672996
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.
Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
Clin Exp Rheumatol; 1996; 14(4):413-6. PubMed ID: 8871841
[TBL] [Abstract][Full Text] [Related]
3. Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Lodi L; Bisighini G; Portioli I
J Rheumatol; 1992 Jan; 19(1):74-9. PubMed ID: 1556703
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis.
Elkayam O; Yaron I; Shirazi I; Yaron M; Caspi D
Rheumatol Int; 2000; 19(3):101-5. PubMed ID: 10776688
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
6. Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet.
Simon P; Pfoehler C; Bergner R; Schreiber M; Pfreundschuh M; Assmann G
Clin Exp Rheumatol; 2012; 30(1):45-50. PubMed ID: 22274638
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
[TBL] [Abstract][Full Text] [Related]
8. Therapy with cyclosporine in psoriatic arthritis.
Olivieri I; Salvarani C; Cantini F; Macchioni L; Padula A; Niccoli L; Boiardi L; Portioli I
Semin Arthritis Rheum; 1997 Aug; 27(1):36-43. PubMed ID: 9287388
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis.
Spadaro A; Taccari E; Sensi F; Riccieri V; Sili Scavalli A; Zoppini A
Clin Rheumatol; 1998; 17(1):83-5. PubMed ID: 9586691
[No Abstract] [Full Text] [Related]
10. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
[TBL] [Abstract][Full Text] [Related]
11. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
Pasero G; Priolo F; Marubini E; Fantini F; Ferraccioli G; Magaro M; Marcolongo R; Oriente P; Pipitone V; Portioli I; Tirri G; Trotta F; Della Casa-Alberighi O
Arthritis Rheum; 1996 Jun; 39(6):1006-15. PubMed ID: 8651963
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate.
Boiardi L; Macchioni P; Meliconi R; Pulsatelli L; Facchini A; Salvarani C
Clin Exp Rheumatol; 1999; 17(4):419-25. PubMed ID: 10464551
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
14. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ
Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids.
Lee D; Hong SK; Park SW; Hur DY; Shon JH; Shin JG; Hwang SW; Sung HS
Exp Dermatol; 2010 Feb; 19(2):145-7. PubMed ID: 19758343
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis.
Sarzi-Puttini P; Cazzola M; Panni B; Turiel M; Fiorini T; Belai-Beyene N; Chèrié-Lignièré EL
Rheumatol Int; 2002 Apr; 21(6):234-8. PubMed ID: 12036210
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis.
Camilleri JP; Amos N; Williams BD; Emery P; Williams LA; Jessop JD
J Rheumatol; 2001 Dec; 28(12):2576-8. PubMed ID: 11764199
[TBL] [Abstract][Full Text] [Related]
19. [The use of measuring serum soluble IL-2 receptor levels in cyclosporine-A treated lupus nephritis].
Zheng X; Lin M; Cui X; Yao Q; Zhou G; Guo Z
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):338-41. PubMed ID: 8586406
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of clinical and radiological progression in psoriatic arthritis.
Gladman DD; Stafford-Brady F; Chang CH; Lewandowski K; Russell ML
J Rheumatol; 1990 Jun; 17(6):809-12. PubMed ID: 2388203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
